A positive top-line readout from a phase 3 trial has emboldened Incyte to seek the FDA’s blessing for the company’s Monjuvi ...

The first part of this series focused on the section of Gerrard Street East between Broadview Avenue and the Carlaw-Pape ...

US biotech Incyte (Nasdaq: INCY) yesterday announced positive top-line results from the pivotal Phase III frontMIND trial ...

The targets are moving, more diffuse, it’s more complex. Before, the enemy was clear. Now some are wearing suits, some are ...

A former AIIMS doctor has criticized the ‘Temple’ device worn by Zomato CEO Deepinder Goyal, calling it scientifically ...

A new chip-based quantum memory uses nanoprinted “light cages” to trap light inside atomic vapor, enabling fast, reliable ...

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs ...

Earnings reports reveal how social inflation, litigation finance, and nuclear verdicts are reshaping insurance risk and ...

An interior designer recommends this simple design trick to transform a space. Changing bulb temperatures and lampshades ...

Start the year without a bang: as two in five of the UK population suffer from harmful levels of noise, the search for ...

China’s decision to halt work on what was meant to be the world’s largest particle accelerator has reshaped the global race ...

The race for leadership in military, intelligence and commercial AI—and for global adoption of US or Chinese models—will only ...